Homehealthcare News

    'You have to make cruel choice amid scarcity of black fungus drug': HC tells Centre, Delhi govt

    'You have to make cruel choice amid scarcity of black fungus drug': HC tells Centre, Delhi govt

    'You have to make cruel choice amid scarcity of black fungus drug': HC tells Centre, Delhi govt
    Profile image

    By CNBCTV18.com  IST (Updated)

    Mini

    The Delhi High Court on Monday asked the Centre and Delhi government to come out with a policy on the distribution of Amphotericin-B, used for treating black fungus patients, and take the "cruel decision" of excluding a certain age group or class of people till the drug is in shortage.

    The Delhi High Court on Monday asked the Central government to form a policy on the distribution of Amphotericin-B, the drug used to treat black fungus patients.
    The court also asked them to take the "cruel decision" of excluding a certain age group or class of people till the drug is in shortage.
    Citing an example, it said that if there are two patients -- one is 80-year-old and other is 35-year-old and there is only one dose of medicine then it should be given to whom. That's a bullet you have to take it and you have to take this cruel decision which is not at all an easy task, a bench of Justices Vipin Sanghi and Jasmeet Singh, making it clear that it was not at all saying life of any person is less important than another.
    The bench asked them not to leave the decision to the doctors and form a clear policy in this regard and told the counsel for the Centre and Delhi government to come back with instructions on Tuesday.
    The court also told the Centre's counsel that as a matter of policy, the government will have to say till the drug is not available in appropriate quantity, it will have to leave some patients and you have to exclude some. The 80-year-old man has lived his life, he has no more responsibility, of course, there is support from his side to the family. Whereas, the 35-year-old patient has two children to support. If we have to make a cruel choice, we have to take a decision. Will you give it to the 80-year-old patient or to whom who has two children to support, the bench said.
    Earlier, the Centre on Friday placed a report giving the steps taken by it to source the medicine and overcome shortages.
    According to the Union Health Ministry, people catch mucormycosis by coming in contact with the fungal spores in the environment. It can also develop on the skin after the fungus enters the skin through a cut, scrape, burn, or another type of skin trauma. The disease is being detected among patients who are recovering or have recovered from COVID-19. Moreover, anyone who is diabetic and whose immune system is not functioning well needs to be on the guard against this, the ministry has said.
    (With inputs from PTI)
     
     
    Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
    arrow down

      Most Read

      Market Movers

      View All
      CompanyPriceChng%Chng